Q4 - 2008
Global Vaccine Commercializatio
Part One: Competitive Challenge
Global pharmaceutical, generics and biotech industry news
Stratégies pour l’innovation pharmaceutique
Financial Advisory Newsletter
Q3 - 2008
Influenza: the Avoidable Killer
SCRIP Drug Market developments Influenza is a disease of global health significance against which the fight is far from over.
Pharmaceutical Executive Many say licensing is the new R&D. The thrid quarter of 2007 featured some pricey cherry-picking. Will the unions bear fruit? We've the intersting ones to watch.
Private Equity Newsletter
Cornering the EU Market: the need for Creative Strategies
EBR When it comes to the accessibility of the EU pharmaceutical market, it is clear that a number of factors have changed in the past few years. Evolution or revolution?
Reaching the bottom?
Financial Advisory Newsletter, 2nd Edition
Q2 - 2008